Global Squalane Market, 2020-2026
Squalane is derived by hydrogenation of squalene. It is naturally present in the skin lipid barrier of plants, animals and humans, preventing moisture loss while restoring skin’s suppleness and flexibility. In contrast to squalene, due to the complete saturation of squalane, it is not subject to auto-oxidation. This fact, coupled with lower costs associated with squalane, make it desirable in cosmetic applications. Squalene is a high-end, oil-free moisturizing ingredient used in many cosmetics that, until recently, was extracted primarily from the liver of deep sea sharks. Squalene is quickly absorbed into the skin without leaving an oily residue and also mixes well with other oils, which will augment its demand in personal care and cosmetic products. Squalene is also used in the manufacture of vaccines.
The global squalane market size is projected to reach $226.4 million by 2026, registering a CAGR of 8.58% from 2020 to 2026. The squalane market is segmented on the basis of product, application, and region. The report offers a breakdown of market shares by product, including Animal-based Squalane, Plant-derived Squalane, Biosynthetic Squalane. By application, the squalane market is classified into Cosmetics, Dietary Supplements, Pharmaceuticals. On the basis of region, the squalane industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).
By Product:
The base year of the study is 2019, and forecasts run up to 2026.
Research Objective
The global squalane market size is projected to reach $226.4 million by 2026, registering a CAGR of 8.58% from 2020 to 2026. The squalane market is segmented on the basis of product, application, and region. The report offers a breakdown of market shares by product, including Animal-based Squalane, Plant-derived Squalane, Biosynthetic Squalane. By application, the squalane market is classified into Cosmetics, Dietary Supplements, Pharmaceuticals. On the basis of region, the squalane industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).
By Product:
- Animal-based Squalane
- Plant-derived Squalane
- Biosynthetic Squalane
- Cosmetics
- Dietary Supplements
- Pharmaceuticals
- North America (U.S., Canada, Mexico, etc.)
- Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
- Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
- Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
- South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)
- Amyris, Inc.
- Arbee Biomarine Extracts Pvt. Ltd.
- Efp Biotek
- Kishimoto Special Liver Oil Co., Ltd.
- Maruha Nichiro Corporation
- Nucelis LLC
- Sophim S.A.
- Vestan SA
- Yichun Dahaigui Life Science Co., Ltd.
The base year of the study is 2019, and forecasts run up to 2026.
Research Objective
- To analyze and forecast the market size of global squalane market.
- To classify and forecast global squalane market based on product, application, and region.
- To identify drivers and challenges for global squalane market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global squalane market.
- To conduct pricing analysis for global squalane market.
- To identify and analyze the profile of leading players operating in global squalane market.
- Manufacturers of squalane
- Raw material suppliers
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to squalane
PART 1. INTRODUCTION
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products and Services
4.5.5 Degree of Competition
PART 5. GLOBAL MARKET FOR SQUALANE BY PRODUCT
5.1 Market Overview
5.2 Animal-based Squalane
5.2.1 Market Size and Forecast
5.3 Plant-derived Squalane
5.3.1 Market Size and Forecast
5.4 Biosynthetic Squalane
5.4.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR SQUALANE BY APPLICATION
6.1 Market Overview
6.2 Cosmetics
6.2.1 Market Size and Forecast
6.3 Dietary Supplements
6.3.1 Market Size and Forecast
6.4 Pharmaceuticals
6.4.1 Market Size and Forecast
PART 7. GLOBAL MARKET FOR SQUALANE BY GEOGRAPHY
7.1 Overview
7.1.1 Market Size and Forecast
7.2 North America
7.2.1 Market Size and Forecast
7.2.2 North America: Squalane Market by Country
7.2.2.1 United States
7.2.2.2 Canada
7.2.2.3 Mexico
7.3 Europe
7.3.1 Market Size and Forecast
7.3.2 Europe: Squalane Market by Country
7.3.2.1 Germany
7.3.2.2 France
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Rest of The Europe
7.4 Asia-Pacific
7.4.1 Market Size and Forecast
7.4.2 Asia-Pacific: Squalane Market by Country
7.4.2.1 China
7.4.2.2 India
7.4.2.3 Japan
7.4.2.4 South Korea
7.4.2.5 ASEAN Countries
7.5 Middle East and Africa (MEA)
7.5.1 Market Size and Forecast
7.5.2 MEA: Squalane Market by Country
7.5.2.1 Saudi Arabia
7.5.2.2 South Africa
7.5.2.3 Turkey
7.6 South America
7.6.1 Market Size and Forecast
7.6.2 South America: Squalane Market by Country
7.6.2.1 Brazil
7.6.2.2 Argentina
7.6.2.3 Rest of South America
PART 8. COMPETITIVE LANDSCAPE
8.1 Market Share
8.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships
PART 9. KEY COMPETITOR PROFILES
9.1 Amyris, Inc.
9.2 Arbee Biomarine Extracts Pvt. Ltd.
9.3 Efp Biotek
9.4 Kishimoto Special Liver Oil Co., Ltd.
9.5 Maruha Nichiro Corporation
9.6 Nucelis LLC
9.7 Sophim S.A.
9.8 Vestan SA
9.9 Yichun Dahaigui Life Science Co., Ltd.
*LIST IS NOT EXHAUSTIVE
PART 10. PATENT ANALYSIS
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis
DISCLAIMER
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products and Services
4.5.5 Degree of Competition
PART 5. GLOBAL MARKET FOR SQUALANE BY PRODUCT
5.1 Market Overview
5.2 Animal-based Squalane
5.2.1 Market Size and Forecast
5.3 Plant-derived Squalane
5.3.1 Market Size and Forecast
5.4 Biosynthetic Squalane
5.4.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR SQUALANE BY APPLICATION
6.1 Market Overview
6.2 Cosmetics
6.2.1 Market Size and Forecast
6.3 Dietary Supplements
6.3.1 Market Size and Forecast
6.4 Pharmaceuticals
6.4.1 Market Size and Forecast
PART 7. GLOBAL MARKET FOR SQUALANE BY GEOGRAPHY
7.1 Overview
7.1.1 Market Size and Forecast
7.2 North America
7.2.1 Market Size and Forecast
7.2.2 North America: Squalane Market by Country
7.2.2.1 United States
7.2.2.2 Canada
7.2.2.3 Mexico
7.3 Europe
7.3.1 Market Size and Forecast
7.3.2 Europe: Squalane Market by Country
7.3.2.1 Germany
7.3.2.2 France
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Rest of The Europe
7.4 Asia-Pacific
7.4.1 Market Size and Forecast
7.4.2 Asia-Pacific: Squalane Market by Country
7.4.2.1 China
7.4.2.2 India
7.4.2.3 Japan
7.4.2.4 South Korea
7.4.2.5 ASEAN Countries
7.5 Middle East and Africa (MEA)
7.5.1 Market Size and Forecast
7.5.2 MEA: Squalane Market by Country
7.5.2.1 Saudi Arabia
7.5.2.2 South Africa
7.5.2.3 Turkey
7.6 South America
7.6.1 Market Size and Forecast
7.6.2 South America: Squalane Market by Country
7.6.2.1 Brazil
7.6.2.2 Argentina
7.6.2.3 Rest of South America
PART 8. COMPETITIVE LANDSCAPE
8.1 Market Share
8.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships
PART 9. KEY COMPETITOR PROFILES
9.1 Amyris, Inc.
9.2 Arbee Biomarine Extracts Pvt. Ltd.
9.3 Efp Biotek
9.4 Kishimoto Special Liver Oil Co., Ltd.
9.5 Maruha Nichiro Corporation
9.6 Nucelis LLC
9.7 Sophim S.A.
9.8 Vestan SA
9.9 Yichun Dahaigui Life Science Co., Ltd.
*LIST IS NOT EXHAUSTIVE
PART 10. PATENT ANALYSIS
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY